Despite the advances of modern medicine, the threat of chronic illness, dis
figurement, or death that can result from parasitic infection still affects
the majority of the world population, retarding economic development. For
most parasitic diseases, current therapeutics often leave much to be desire
d in terms of administration regime, toxicity, or effectiveness and potenti
al vaccines are a long way from market. Our best prospects for identifying
new targets for drug, vaccine, and diagnostics development and for dissecti
ng the biological basis of drug resistance, antigenic diversity, infectivit
y and pathology lie in parasite genome analysis, and international mapping
and gene discovery initiatives are under way for a variety of protozoan and
helminth parasites. These are far from ideal experimental organisms, and t
he influence of biological and genomic characteristics on experimental appr
oaches is discussed, progress is reviewed and future prospects are examined
. BioEssays 1999,21.131-147. (C) 1999 John Wiley a Sons, Inc.